Efficacy Of GSK’s Lamictal In Grand Mal Seizures Demonstrated In Pediatrics Study
This article was originally published in The Pink Sheet Daily
The anti-epileptic lamotrigine is not currently indicated for the treatment of primary generalized tonic-clonic seizures.
You may also be interested in...
Next in the pipeline for GSK’s epilepsy franchise is an XR formulation for once-daily dosing.
The dual GLP-1/GIP agonist outpaced Novo's blockbuster GLP-1 analogue at all three doses, including the important low dose, on A1C reduction and weight reduction in patients with type 2 diabetes.